← Back to Search
Proton Therapy For Malignant Pleural Mesothelioma After Extrapleural Pleuropneumonectomy.
J. Krayenbuehl, M. Hartmann, A. Lomax, S. Kloeck, E. Hug, I. Ciernik
Published 2010 · Medicine
Download PDFAnalyze on Scholarcy
PURPOSE To perform comparative planning for intensity-modulated radiotherapy (IMRT) and proton therapy (PT) for malignant pleural mesothelioma after radical surgery. METHODS AND MATERIALS Eight patients treated with IMRT after extrapleural pleuropneumonectomy (EPP) were replanned for PT, comparing dose homogeneity, target volume coverage, and mean and maximal dose to organs at risk. Feasibility of PT was evaluated regarding the dose distribution with respect to air cavities after EPP. RESULTS Dose coverage and dose homogeneity of the planning target volume (PTV) were significantly better for PT than for IMRT regarding the volume covered by >95% (V95) for the high-dose PTV. The mean dose to the contralateral kidney, ipsilateral kidney, contralateral lung, liver, and heart and spinal cord dose were significantly reduced with PT compared with IMRT. After EPP, air cavities were common (range, 0-850 cm(3)), decreasing from 0 to 18.5 cm(3)/day. In 2 patients, air cavity changes during RT decreased the generalized equivalent uniform dose (gEUD) in the case of using an a value of < - 10 to the PTV2 to <2 Gy in the presence of changing cavities for PT, and to 40 Gy for IMRT. Small changes were observed for gEUD of PTV1 because PTV1 was reached by the beams before air. CONCLUSION Both PT and IMRT achieved good target coverage and dose homogeneity. Proton therapy accomplished additional dose sparing of most organs at risk compared with IMRT. Proton therapy dose distributions were more susceptible to changing air cavities, emphasizing the need for adaptive RT and replanning.
This paper references
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
E. Hansen (2006)
The European mesothelioma epidemic
J. Peto (1999)
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
F. Sterzing (2008)
Reporting and analyzing dose distributions: a concept of equivalent uniform dose.
A. Niemierko (1997)
Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus.
A. Lomax (2003)
Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy.
Si Young Jang (2008)
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
S. Wang (2006)
Radical radiotherapy for cervix cancer: the effect of waiting time on outcome.
C. E (2005)
Multidisciplinary treatment of malignant pleural mesothelioma.
G. Ceresoli (2007)
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
V. Gupta (2005)
Low-dose megavoltage cone-beam CT for radiation therapy.
J. Pouliot (2005)
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
Jerry Barker (2004)
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
X. Xu (2008)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
Corrigendum to “Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience” [Lung Cancer 49S1 (2005) S83–S86]
M. Muenter (2005)
Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
J. Krayenbuehl (2007)
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?
J. O'Daniel (2007)
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
Tim J. Carter (2005)
A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons.
M. Chan (2006)
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization.
E. Pedroni (1995)
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2004)
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
M. Muenter (2005)
Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives.
Qiuwen Wu (2003)
Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
A. Allen (2007)
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
E. Yorke (2005)
Verification of in-treatment tumor position using kilovoltage cone-beam computed tomography: a preliminary study.
K. Nakagawa (2007)
This paper is referenced by
Novel radiation therapy approaches in malignant pleural mesothelioma.
A. Rimner (2012)
Malignant pleural mesothelioma: when is radiation therapy indicated?
Eric RE van Thiel (2011)
Impact of aeration change and beam arrangement on the robustness of proton plans
N. Shusharina (2019)
Utilization of Intensity‐Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States
S. Shaaban (2018)
The need for randomized trials in mesothelioma: let's walk the talk.
T. Treasure (2011)
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
Scientific Report 2010
Centro Nacional de Investigaciones Cardiovasculares (2011)
Chest tumors: current trends of clinical practice
Patricia Tai (2018)
Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy
T. Kimura (2015)
Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series.
H. Pan (2015)
or Incompletely Resected Osteosarcoma
I. Frank Ciernik (2011)
Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma
G. Ozyigit (2016)
In Response to Dr. Russi and Colleagues
M. Scorsetti (2011)
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma
S. Lorentini (2011)
Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Applicable to all and by all?
R. Haas (2015)
Proton beam therapy for malignant pleural mesothelioma.
S. Badiyan (2018)
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?
A. Botticella (2017)
Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
Elvio Grazioso Russi (2011)
Role of new radiation techniques in the treatment of pleural mesothelioma
M. Amichetti (2013)
Radiation Therapy in Mesothelioma
J. Willmann (2019)
Cardiotoxicity of mediastinal radiotherapy.
I. Ratosa (2019)
Consensus Statement on Proton Therapy in Mesothelioma.
J. Zeng (2020)
Intensity‐modulated radiotherapy and volumetric‐modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy
J. Krayenbuehl (2013)
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
I. Ciernik (2011)
Optimizing hemithoracic pleural intensity-modulated radiation therapy for malignant pleural mesothelioma
F. Shaikh (2015)
Medical Treatment of Mesothelioma: Anything New?
N. Takigawa (2011)
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma
A. Chi (2011)
Tomothérapie hélicoïdale dans le traitement du mésothéliome pleural malin : impact des faibles doses sur la toxicité pulmonaire et œsophagienne
J. Hélou (2012)
Is there a single spot size and grid for intensity modulated proton therapy? Simulation of head and neck, prostate and mesothelioma cases.
L. Widesott (2012)
Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma
J. Krayenbuehl (2014)
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma
S. Rice (2019)
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
E. Yorke (2017)See more